Welcome to our dedicated page for NITCHES news (Ticker: NICH), a resource for investors and traders seeking the latest updates and insights on NITCHES stock.
Nitches Inc. reports on its human performance and wellness platform, with recurring updates centered on InTheZone Labs, its wholly owned subsidiary. Company news focuses on nootropic and nutraceutical products for brain health, recovery, focus, energy and wellness, along with domestic formulation, quality controls and compliant marketing.
Updates also cover affiliate and distributor expansion through social-commerce and online channels, GovX-supported programs for service communities, subsidiary commercialization plans, and the company's audit and reporting-status initiatives.
Nitches (OTC:NICH) announced NutraVeri, an AI-powered platform that generates a deterministic supplement readiness score. The same formula and claims always yield the same result, with six dimensions tied to public FDA, FTC, GRAS, NIH, and peer-reviewed sources.
NutraVeri lets founders change ingredients or claims and see which regulatory risk dimensions move, returning a score in about sixty seconds. According to Nitches, the first readiness score is free, takes about two minutes, and requires no account or credit card.
Nitches (OTC PINK:NICH) launched NutraVeri, a platform that screens supplement formulas and marketing claims against public FDA and FTC enforcement records.
The tool scores concepts across six readiness dimensions, indexes 120+ ingredients, highlights high-risk issues, and offers a fast, free initial NutraVeri Score taking about two minutes with no account or payment required.
Nitches (OTC PINK:NICH) announced an expanded NutraVeri Readiness Partner Program that pays manufacturers, agencies, creators, and advisors to refer supplement founders to a free product readiness score before they spend on formula, label, or inventory.
The tool generates a NutraVeri Score in about sixty seconds across six dimensions: formula strength, ingredient evidence, claim risk, dose validation, label readiness, and market fit, using FDA data sources and regulatory guidance. Partners earn tiered commissions when founders upgrade to paid services, and the first 25 approved applicants receive Founding Partner status with temporary enhanced front-end commission rates and priority review.
Nitches (OTC:NICH), via its NutraVeri platform, expanded its Readiness Partner Program, a selective affiliate network that sends supplement founders through a free product readiness score before committing capital.
Partners earn commissions on paid services such as advanced readiness reports, Product Passports, formula reviews, and manufacturing preparation support.
Nitches (OTC:NICH) launched NutraVeri, a product readiness platform that helps founders assess dietary supplement concepts before manufacturing and commercialization. Users submit ingredients, dosages, claims, and targets, and receive a NutraVeri Score across six dimensions, plus optional reports, human formula review, and manufacturing pathway evaluation.
The platform leverages publicly available scientific and regulatory references and offers an initial readiness assessment at no cost via nutraveri.com.
Nitches (OTC:NICH) is developing a supplement readiness platform aimed at founders, brands, and investors who need to validate products before committing capital. The platform will guide users from concept through formulation, claims, labeling, manufacturing preparation, and production pathways, generating a product readiness score and portable product record.
Built on the experience of bringing InTheZone to market and aligned with an FDA-registered, cGMP-aligned manufacturing partner, it is designed as a checkpoint before spending on manufacturing, branding, packaging, and launch. Soft launch access is available via email, with full platform details to follow.
Nitches (OTC:NICH) will soft launch a new consumer platform on Thursday that lets aspiring founders build supplement brands from idea to shelf. Users can design formulas, see real-time scores against federal enforcement and evidence data, and optionally work with FDA-registered manufacturing partners to manufacture and document products.
Nitches (OTC:NICH) is returning to the nutraceutical market, centering on supplements and lifestyle enhancement. It is aligning with an FDA-compliant manufacturing partner and opening its turnkey platform to outside founders, from product concept through distribution, under a rigorous product integrity standard.
Nitches is also developing an intelligence platform that scans ingredients and claims against live enforcement data to generate fast compliance scores and auditable records, aiming to help supplement brands survive regulatory and operational scrutiny.
Nitches (OTC PINK:NICH) provided an update on its financial reporting status and operating plans, highlighting the near completion of a two-year audit with a new PCAOB-registered auditor. The company is working to return to fully reporting status as part of its compliance-first strategy.
Through its subsidiary InTheZone Labs, Nitches is preparing to launch nutraceutical products focused on brain health, recovery, and wellness. The company has developed a milestone-gated spending approach and is finalizing distributor/affiliate onboarding processes. Following audit completion, Nitches plans to announce new corporate collaborations and provide detailed operating updates.
Nitches Inc. (OTC PINK:NICH) has released its March Market Update, highlighting significant growth in its subsidiary InTheZoneLabs, which specializes in nootropics and de-aging supplements. The company reports expanding its affiliate network to 93 partners, driven by social media success, particularly on TikTok.
Key developments include:
- Strong market reception among mothers whose children use Youth Focused products for academic performance
- Partnership with GovX offering 30% discounts to veterans and first responders
- Focus on American-made supplements featuring ingredients like lion's mane mushrooms, L-theanine, alpha-GPC, and phosphatidylserine
- Positioning within the $6.3 trillion global wellness industry
The company emphasizes its commitment to domestic manufacturing, quality control, and transparent sourcing, while targeting the growing de-aging and cognitive enhancement market segments.